This test is most useful if any of these apply to you.
If you have unexplained asthma flares, year-round nasal congestion, or work around mice in a research lab, your immune system may be reacting to a protein called Mus m 1 (the major house mouse allergen). This blood test looks for IgE (immunoglobulin E, the antibody class that drives allergic reactions) specifically targeting that mouse protein.
Mouse allergen is a surprisingly common indoor exposure in urban housing and a leading cause of occupational allergy in research facilities. A positive result tells you your immune system has been primed by mouse exposure, which matters because mouse sensitization is closely tied to asthma severity, emergency visits, and work-related respiratory disease.
Mus m 1 is the major mouse urinary allergen, the protein responsible for most allergic reactions to house mice. When you inhale dust containing mouse urine or dander, a sensitized immune system produces IgE antibodies that latch onto Mus m 1. This blood test quantifies those antibodies. A detectable level means your body has built an allergic memory of mouse exposure. The size of the number gives a rough sense of how strong that immune response is.
In a survey of over a thousand blood samples, only a small fraction had detectable IgE to mouse, and roughly 1% had high titers. So a high reading is uncommon, but when it appears, it carries weight.
Mouse sensitization is one of the strongest indoor allergen links to asthma morbidity, particularly in inner-city environments. Among inner-city preschool children with asthma, roughly a quarter were sensitized to mouse by IgE or skin testing. In sensitized preschoolers, higher household Mus m 1 exposure was linked to more symptom days, more rescue inhaler use, and higher odds of emergency visits and hospitalization.
In Boston women, serum IgE to mouse urinary allergen and to recombinant Mus m 1 was strongly associated with physician-diagnosed asthma and multiple measures of poor asthma control, even after adjusting for other factors. Mouse IgE also appears to interact with viral triggers: in children, higher mouse-specific IgE and a rise in that IgE during rhinovirus infection were associated with more severe asthma exacerbations.
If you handle mice in a research setting, this test is especially relevant. A meaningful share of mouse-exposed workers show IgE sensitization to mouse proteins, with reviews citing a wide prevalence range across facilities depending on cage design, ventilation, and protective equipment. Workers in open-cage facilities show more sensitization and symptoms than those in individually ventilated cage facilities.
Sensitization in lab workers can be to mouse urine proteins like Mus m 1, mouse epithelium (skin and dander), or both. Studies show that testing only one of these can miss cases, which is why allergists often order both Mus m 1 IgE and mouse epithelium IgE together. Skin prick testing tends to outperform blood IgE for predicting clinically relevant mouse allergy in this population, but blood testing avoids the need for an in-person procedure and is a practical first step for someone ordering their own labs.
You might expect that more exposure always means more sensitization. The data show something more complicated. Moderate household Mus m 1 exposure carries the highest odds of IgE sensitization, while very high exposure is associated with somewhat lower sensitization, possibly because of immune tolerance at extreme exposure levels. In occupational settings, the opposite pattern shows up: workers in open-cage labs with high aerosolized exposure have more sensitization than those in ventilated cage systems.
What this means for you: a positive Mus m 1 IgE result reflects how your specific immune system has responded to your specific exposure pattern, not a simple linear function of how many mice are nearby. The test answers a question about you, not just your environment.
Two other tests are commonly used to evaluate mouse allergy: skin prick testing with mouse extract, and nasal allergen challenge (where mouse allergen is sprayed into the nose under medical supervision). In a study of laboratory workers compared against nasal challenge as the reference standard, skin prick testing had the strongest predictive value for true mouse allergy. Mouse-specific blood IgE was less accurate as a stand-alone test.
That does not make this blood test useless. It makes it a starting point. A positive blood IgE flags sensitization that warrants further evaluation. A negative result with classic symptoms still warrants follow-up, because some sensitized individuals show positive on one test type and negative on another.
A single Mus m 1 IgE reading is a snapshot. What matters more is whether your level changes over time as your exposure changes. If you move out of a building with rodent activity, change jobs, or your lab adopts ventilated cages, your IgE level can shift. Tracking the trend lets you see whether interventions are actually changing your immune burden.
A reasonable approach is to get a baseline reading now, retest in 3 to 6 months if you have made meaningful changes to your exposure or symptoms, and then at least annually if you remain in a high-exposure environment. In children, mouse-specific IgE has been observed to rise acutely during rhinovirus infection, so timing your draw outside of an acute respiratory illness gives a more representative reading.
If your Mus m 1 IgE comes back positive and you have respiratory symptoms, the next steps depend on the rest of your clinical picture. Consider ordering mouse epithelium IgE alongside it, since some people are sensitized to one but not the other. Total IgE provides context for whether you have a generally atopic immune system. If asthma is part of the picture, a workup with a pulmonologist or allergist makes sense, often combining skin prick testing, lung function tests, and a careful exposure history.
If the result is positive but you have no symptoms, the finding still has value: it identifies you as someone whose immune system has reacted to mouse exposure, and it raises the importance of exposure reduction at home and at work to help prevent escalation to clinical asthma or rhinitis. The general principle in allergy is that sensitization plus exposure is what drives disease, and reducing one or both is the lever you can pull.
A few situations can distort a single reading or its interpretation:
Evidence supports testing mainly for people with clear mouse exposure and compatible allergic or asthmatic symptoms. That includes residents of urban housing with rodent activity, parents of children with hard-to-control asthma in inner-city settings, and workers in research labs that handle mice. There is no strong evidence that broad population screening of asymptomatic people adds value, and the test is most useful when paired with a specific clinical question about your exposure and your symptoms.
Evidence-backed interventions that affect your House Mouse (Mus m 1) IgE level
House Mouse (Mus m 1) IgE is best interpreted alongside these tests.
House Mouse (Mus m 1) IgE is included in these pre-built panels.